Lung for Long Gasp No More

Wednesday, April 26, 2017
Bussinesswireind

Business Wire India Data emerging from Press Club of India press panic button High time to know your lung number and reinstate its power JOIN THE BREATHE FREE MOVEMENT AND SAVEYOURLUNGS Lungs in Delhi seem to be in dire straits In the midst of ever thickening air pollution and lifestyle gone ast..

Enamine to Collaborate with EMBL for Cancer Drug Discovery Research

Wednesday, April 26, 2017

Enamine Ltd a chemical company producer of novel chemical building blocks and screening libraries and the European Molecular Biology Laboratory EMBL have agreed to establish a collaboration whereby Enamine provides library synthesis medicinal chemistry and biological services for the discovery and d..

Sanofi and Regeneron Announce FDA Approval of a New OnceMonthly Dosing Option for Praluent alirocumab Injection

Wednesday, April 26, 2017

Sanofi and Regeneron Pharmaceuticals Inc today announced that the US Food and Drug Administration FDA approved the companies39 new supplemental Biologics License Application sBLA for a oncemonthly every four weeks 300 mg dose of Praluent alirocumab Injection for the treatment of adults with high low..

Aquinnah Pharmaceuticals Receives 10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease

Wednesday, April 26, 2017

Aquinnah Pharmaceuticals a privately held biotechnology company focused on RNA binding proteins for neurodegenerative disease announced today that two additional pharmaceutical companies Pfizer Inc NYSE PFE and AbbVie Inc NYSE ABBV have invested in Aquinnah39s work to treat ALS Amyotrophic Lateral S..

CPhI expert calls for ANDA approvals to be reduced by twothirds in order to lower drug costs

Wednesday, April 26, 2017

Girish Malhotra President of EPCOT International and CPhI Worldwide Annual Industry Report member discusses the necessity of time reduction for ANDA approvals arguing that if the current approval time can be reduced from ten months to three months drug costs will decrease Malhotra states that in ..

Integra LifeSciences Reports First Quarter 2017 Financial Results

Wednesday, April 26, 2017
GLOBE NEWSWIRE

Revenue Increased 92 to 2586 million Organic Revenue Increased 64 Reported EPS of 008 Adjusted EPS of 039 PLAINSBORO NJ April 26 2017 GLOBE NEWSWIRE Integra LifeSciences Holdings Corporation NASDAQIART a leading global medical technology company today reported its financial results for the ..

ForeSight Medical completes SOC 2 Type 2 data security examination

Wednesday, April 26, 2017
GLOBE NEWSWIRE

TAMPA Fla April 26 2017 GLOBE NEWSWIRE ForeSight Medical a national leader in controlling costs of surgical implants in the workers compensation arena has demonstrated its commitment to data security and privacy by completing a rigorous outside audit of its Service Organization Controls 2 Type 2..

MacroGenics to Present at Two Upcoming Investor Conferences in May

Wednesday, April 26, 2017
GLOBE NEWSWIRE

Rockville MD April 26 2017 GLOBE NEWSWIRE MacroGenics Inc Nasdaq MGNX a clinicalstage biopharmaceutical company focused on discovering and developing innovative monoclonal antibodybased therapeutics for the treatment of cancer as well as autoimmune disorders and infectious diseases toda..

Karamba Security and eSOL in Cooperation with Asgent Demonstrate How to Stop Automotive and Medical IoT Hacks at ESEC 2017

Wednesday, April 26, 2017
GLOBE NEWSWIRE

ANN ARBOR Mich HOD HASHARON Israel and TOKYO April 26 2017 GLOBE NEWSWIRE Karamba Security a provider of autonomous cybersecurity solutions for connected and autonomous vehicles and eSOL a leading developer of realtime embedded software solutions have partnered to demonstrate how their integra..

CASMED to Report FirstQuarter 2017 Financial Results and Hold Conference Call on May 3

Wednesday, April 26, 2017
GLOBE NEWSWIRE

BRANFORD Conn April 26 2017 GLOBE NEWSWIRE CAS Medical Systems Inc NASDAQCASM CASMED a leader in noninvasive monitoring of cerebral oxygenation announces that it will report financial results for the first quarter of 2017 on Wednesday May 3 2017 prior to the markets opening Management will host ..

BioSig Technologies to Attend the Heart Rhythm Societys Scientific Sessions May 1013 in Chicago

Wednesday, April 26, 2017
GLOBE NEWSWIRE

Minneapolis MN April 26 2017 GLOBE NEWSWIRE BioSig Technologies IncOTCQBBSGM a medical device company developing a proprietary platform designed to address an unmet technology need for the 4 billion electrophysiology EP marketplace today announced that the Company will be attending the Heart R..

Onconova Therapeutics Inc to Present at PIONEERS 2017 Presented by Joseph Gunnar Co LLC

Wednesday, April 26, 2017
GLOBE NEWSWIRE

NEWTOWN Pa April 26 2017 GLOBE NEWSWIRE Onconova Therapeutics Inc NASDAQONTX a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer today announced that Dr Ramesh Kumar President CEO will present an overview at PIONEERS 2017 pre..

Shire Granted EU Conditional Marketing Authorisation for Natpar Parathyroid Hormone for the Treatment of Patients with Chronic Hypoparathyroidism

Wednesday, April 26, 2017
PR Newswire

ZUG Switzerland April 26 2017 PRNewswire Shire plc LSE SHP NASDAQ SHPG today announced that the European Commission EC has granted Conditional Marketing Authorisation for Natpar rhPTH184 the first recombinant human protein with the full length 84amino acid sequence of endogenous parathyroid horm..

First patient treated in Turnstones lung cancer trial combining novel viral cancer therapy with approved checkpoint inhibitor

Wednesday, April 26, 2017
PR Newswire

Combination of Turnstones oncolytic viral immunotherapy with checkpoint inhibitors showed promising results in preclinical testing OTTAWA April 26 2017 PRNewswire Turnstone Biologics Inc announced today that treatment has been initiated on the first patient in the companys Phase III clinical ..

United Therapeutics Corporation Reports First Quarter 2017 Financial Results

Wednesday, April 26, 2017
PR Newswire

SILVER SPRING Md and RESEARCH TRIANGLE PARK NC April26 2017 PRNewswire United Therapeutics Corporation NASDAQ UTHR today announced its financial results for the first quarter ended March31 2017 Our quarterly financial growth trends are slower than we would like as we are seeing more patients sta..

3D Systems and United Therapeutics Announce Bioprinting Agreement

Wednesday, April 26, 2017
PR Newswire

ROCK HILL SC and SILVER SPRING Md April 26 2017 PRNewswire 3D Systems NYSE DDD and United Therapeutics Corporation NASDAQ UTHR today announced plans to develop solidorgan scaffolds for human transplants The multiyear collaboration and development agreement combines the 3D printing and precisio..

ARMO BioSciences Appoints Pierre Legault to Board of Directors

Wednesday, April 26, 2017
PR Newswire

REDWOOD CITY Calif April 26 2017 PRNewswire ARMO BioSciences Inc a latestage immunooncology company today announced the appointment of Pierre Legault to its Board of Directors Mr Legault will serve as Chairman of the Audit Committee Pierre is an experienced executive and board member who has ext..

Egalet to Report First Quarter 2017 Financial Results During Investor Day on May 10 2017 in New York

Wednesday, April 26, 2017
PR Newswire

WAYNE Pa April 26 2017 PRNewswire Egalet CorporationNasdaq EGLT Egaleta fully integrated specialty pharmaceutical company focused on developing manufacturing and commercializing innovative treatments for pain and other conditions today announced it will host an investor event on Wednesday May 10 2..

Research Reports Initiation on Medical Research Stocks Alere OpGen Novadaq Technologies and PRA Health

Wednesday, April 26, 2017
PR Newswire

NEW YORK April 26 2017 PRNewswire Four equities have been lined up for review on StockCallerscom today and they are Alere Inc NYSE ALR OpGen Inc NASDAQ OPGN Novadaq Technologies Inc NASDAQ NVDQ and PRA Health Sciences Inc NASDAQ PRAH These stocks belong to the Medical Laboratories and Research c..

Asterias Announces Publication of Positive Phase 2 Data on ASTVAC1 for the Treatment of Acute Myeloid Leukemia AML in Cancer

Wednesday, April 26, 2017
PR Newswire

FREMONT Calif April 26 2017 PRNewswire Asterias Biotherapeutics Inc NYSE MKT AST a biotechnology company focused on the emerging field of regenerative medicine today announced that the results from its completed Phase 2 clinical trial of ASTVAC1 are now available online in Cancer a leading peerrev..

TOP